(Q36715513)

15 August 2017

1 reference

title

Copper: role of the 'endogenous' and 'exogenous' metal on the development and control of inflammatory processes (English)

1 reference

15 August 2017

Roberto Milanino

1

1 reference

15 August 2017

Virginia Buchner

series ordinal

2

1 reference

15 August 2017

language of work or name

1 reference

1 July 2006

1 reference

Reviews on Environmental Health

15 August 2017

published in

1 reference

15 August 2017

volume

21

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

153-215

1 reference

History of Ancient Copper Smelting Pollution During Roman and Medieval Times Recorded in Greenland Ice

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti-arthritic drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Copper chelates as possible active forms of the antiarthritic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Superoxide dismutase activity of low molecular weight Cu2+ -chelates studied by pulse radiolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Adjuvant Arthritis in young copper-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Distribution of prostaglandins in inflammatory exudate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Copper and zinc status in rats with acute inflammation: focus on the inflamed area

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Copper and aspirin treatment increase the antioxidant activity of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Effects of copper depletion andd-penicillamine treatment on the ocular inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Plasma protein response in experimental inflammation in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Determination of histaminase (diamine oxidase) activity byo-dianisidine test: Interference of ceruloplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Copper and zinc status in adjuvant-arthritic rat: studies on blood, liver, kidneys, spleen and inflamed paws

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Effects of copper aspirinate and aspirin on tissue copper, zinc, and iron concentrations following chronic oral treatment in the adjuvant arthritic rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Biodistribution of 64Cu in inflamed rats following administration of two anti-inflammatory copper complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Trace metal composition of synovial fluid and blood serum of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Serum copper and caeruloplasmin in ankylosing spondylitis, systemic sclerosis, and morphea

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Trace elements in serum and urine of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Synovial fluid copper and related variables in rheumatoid and degenerative arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Predictive clinical and laboratory parameters for serum zinc and copper in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Nutritional status and growth in juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Copper homeostasis in infant nutrition: deficit and excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Involvement of chloride channels in hepatic copper metabolism: ClC-4 promotes copper incorporation into ceruloplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Concerning the merits of copper aspirin as a potential anti-inflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Interaction of Cu(II) 3,5-diisopropylsalicylate with human serum albumin--an evaluation of spectroscopic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Expression of Glycosaminoglycans and Small Proteoglycans in Wounds: Modulation by the Tripeptide–Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

The effect of topical tripeptide-copper complex on healing of ischemic open wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Skin irritation potential of copper compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Practical recommendations and new therapies for Wilson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Lipid vesicles and other colloids as drug carriers on the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

The use of sterically stabilized liposomes to treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Evaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Trace elements in human physiology and pathology. Copper

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Dopamine beta-hydroxylase of adrenal chromaffin granules: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Cell surface monoamine oxidases: enzymes in search of a function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Bacterial copper transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Understanding the mechanism and function of copper P-type ATPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Modulation of the nitric oxide pathway by copper in glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

A new role for monoamine oxidases in the modulation of macrophage-inducible nitric oxide synthase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

An Enzyme-Based Theory of Obligate Anaerobiosis: The Physiological Function of Superoxide Dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Ceruloplasmin: an acute phase reactant that scavenges oxygen-derived free radicals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

An in vivo, ex vivo and in vitro comparative study of activity of copper oligopeptide complexes vs Cu(II) ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Enhancement of antioxidant and anti-inflammatory activities of bioflavonoid rutin by complexation with transition metals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

The relationship of some copper (II) complexes of facultative tetrathioethers to the coordination environment in the “blue” copper proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Metal complexes of antiinflammatory drugs. Part VII: Salsalate complex of copper(II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Non-steroidal anti-inflammatory drug-copper complex modulation of polymorphonuclear leukocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Oxidative stress in phagocytes--"the enemy within".

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Participation of superoxide anions at the prostaglandin phase of carrageenan foot-oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

VAP-1: an adhesin and an enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Effects of copper status on neutrophil function, superoxide dismutase, and copper distribution in steers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Absence of the Endothelial Oxidase AOC3 Leads to Abnormal Leukocyte Traffic In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

Role of prostaglandin endoperoxide PGG2 in inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2006.21.3.153

10.1515/REVEH.2006.21.3.153

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference